BD, a leading global medical technology company, announced that the BD MAX™ Respiratory Viral Panel, a new molecular diagnostic combination test for SARS-CoV-2, Influenza A + B and Respiratory Syncytial Virus, has been CE marked to the IVD directive 98/79/EC.
June 30, 2022
· 3 min read